LMLN and leishmaniasis: In this study, we aimed to analyze the multi-copy GP63 gene in three different Leishmania species and determine a novel vaccine candidate antigen against leishmaniasis using sequencing data of locally detected Leishmania strains isolated from humans and in silico approaches.